Actively Recruiting
Long-Term Follow-up of Patients Treated With Miltenyi Cell and Gene Therapies
Led by Miltenyi Biomedicine GmbH · Updated on 2025-11-26
40
Participants Needed
7
Research Sites
869 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The goal of this Long-Term Follow-Up Trial is to assess long-term safety and efficacy of Miltenyi CAR T treatment.
CONDITIONS
Official Title
Long-Term Follow-up of Patients Treated With Miltenyi Cell and Gene Therapies
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patient underwent treatment with a Miltenyi CAR T cell therapy in one of the parent trials at least 12 months prior to enrollment in long-term follow-up.
- Patient has provided informed consent prior to enrollment.
You will not qualify if you...
History of severe allergic reactions to study medication Currently pregnant or breastfeeding Recent participation in another clinical trial within the last 30 days Presence of uncontrolled medical conditions that could affect safety
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 7 locations
1
Charité Universitätsmedizin Berlin
Berlin, Germany, 13353
Actively Recruiting
2
Universitätsklinikum Köln
Cologne, Germany, 50937
Active, Not Recruiting
3
Uniklinikum Erlangen
Erlangen, Germany, 91054
Active, Not Recruiting
4
Universitätsmedizin Göttingen
Göttingen, Germany, 37075
Active, Not Recruiting
5
Universitätsklinikum Münster
Münster, Germany, 48149
Actively Recruiting
6
Universitätsklinikum Tübingen
Tübingen, Germany, 72076
Active, Not Recruiting
7
Universitäts-Kinderklinik Würzburg
Würzburg, Germany, 97080
Active, Not Recruiting
Research Team
C
Clinical Trial Manager
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
OTHER
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here